News

The pharma company said the drug combined with eltrombopag demonstrated a significant improvement in time to treatment ...
Novartis AG said an experimental medicine helped patients with an autoimmune disease in late-stage studies, offering a boost ...
In the final overall survival analysis, researchers pitted Lu-177-PSMA-617 (Pluvicto) against an ARPI in the second-line ...
Novartis has been evaluating a bid for Avidity, which had a market value of about $5.8bn at market close on Wednesday, and ...
Swiss ministers have met with senior executives of pharmaceutical companies Roche and Novartis to discuss the outlook for the ...
The Swiss government met with executives of Roche Holding AG and Novartis AG to discuss the pharmaceutical industry’s ...
Novartis may have abandoned one Sjögren's syndrome asset this year, but it looks like the drugmaker has a winner on its hands ...
Avidity Biosciences (NASDAQ:RNA) stock surged 18% Wednesday after the Financial Times reported that Swiss pharmaceutical ...
And if you're looking for top dividend-paying companies to put your money in right now, let's consider two excellent ...
The state of Maine is being sued by a pharmaceutical company over its discount drug program. Novartis, a New Jersey-based company, is seeking to end Maine’s regulation of the 340B Drug Pricing Program ...
Novartis today announced positive top-line results from its Phase III trials evaluating ianalumab (VAY736) in adults with ...
The overwhelming federal nature of this subject is apparent,” the lawsuit alleges. “States are not free to tinker with ...